Average Co-Inventor Count = 4.13
ph-index = 21
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (17 from 1,210 patents)
2. Novartis Ag (12 from 3,923 patents)
3. Immunogen, Inc. (11 from 255 patents)
4. Children's Medical Center Corporation (5 from 1,036 patents)
5. Harvard College (4 from 2,967 patents)
6. Immutep S.a.s. (3 from 9 patents)
7. Genentech, Inc. (2 from 3,223 patents)
32 patents:
1. 12252535 - Antibody molecules to LAG-3 and uses thereof
2. 11827704 - Antibody molecules to PD-1 and uses thereof
3. 11155620 - Method of detecting TIM-3 using antibody molecules to TIM-3
4. 10981990 - Antibody molecules to TIM-3 and uses thereof
5. 10844135 - Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said
6. 10752687 - Antibody molecules to PD-1 and uses thereof
7. 10711060 - Antibody molecules to LAG-3 and uses thereof
8. 10472419 - Antibody molecules to TIM-3 and uses thereof
9. 9908936 - Antibody molecules to LAG-3 and uses thereof
10. 9884913 - Antibody molecules to TIM-3 and uses thereof
11. 9815898 - Antibody molecules to PD-1 and uses thereof
12. 9683048 - Antibody molecules to PD-1 and uses thereof
13. 9605070 - Antibody molecules to TIM-3 and uses thereof
14. 8198417 - Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
15. 8163888 - Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates